How Many Levels of Surgical Pathology Are There?

There are six levels of surgical pathology in the United States, numbered I through VI. Each level corresponds to a specific Current Procedural Terminology (CPT) code, ranging from 88300 for the simplest specimens to 88309 for the most complex. The levels reflect how much work a pathologist needs to do to examine and diagnose a tissue sample, and they determine how the lab bills for its services. But the six levels are far from equally common, and the rules for assigning them involve more judgment calls than most people realize.

What the Six Levels Actually Mean

The American Medical Association’s CPT manual assigns every type of surgical specimen to one of six tiers. The tiers are built around a basic principle: as the level number rises, the specimen requires more effort to examine, more clinical context to interpret, and more expertise to diagnose. Here is what each level covers in practice.

• Level I (88300): Gross examination only. The pathologist (or pathologist assistant) looks at the specimen with the naked eye but does not prepare microscope slides. Typical specimens include tissue that has already been examined elsewhere, foreign bodies removed from wounds, and teeth.
• Level II (88302): Gross and microscopic examination of straightforward specimens that rarely yield a surprise diagnosis. Examples include foreskins from patients under age 12, fallopian tubes removed for sterilization, and products of conception that have already been confirmed as such.
• Level III (88304): Gross and microscopic examination of specimens with a somewhat broader diagnostic range. Gallbladders, hernia sacs, tonsils, and varicose veins fall here. The pathologist needs to look under the microscope, but the diagnostic question is usually limited.
• Level IV (88305): Gross and microscopic examination of most routine surgical specimens, including the vast majority of biopsies. Skin biopsies, polyps, bone marrow biopsies, breast biopsies, and most organ tissue samples land at this level. It is the workhorse of surgical pathology.
• Level V (88307): Gross and microscopic examination of complex specimens, often involving cancer staging or multi-part evaluation. Colon resections for tumor, kidney specimens, larynx resections, and uterus specimens with a tumor are common examples.
• Level VI (88309): Gross and microscopic examination of the most complex specimens, which demand the most extensive dissection and slide preparation. Pelvic exenteration specimens, total resections involving multiple organs, and bone resections for tumor fall into this category.

The CPT manual includes a detailed list specifying which specimen types belong to which level. The assignment is based primarily on the specimen type and the clinical situation, not on the final diagnosis. A skin biopsy is coded at Level IV whether the pathologist finds cancer or a benign mole, because the work to process and examine it is the same.

Why Level IV Dominates the Case Mix

If you picture a typical pathology department’s daily workload, Level IV specimens overwhelm everything else. In one large dataset used to train machine-learning models for CPT code prediction, about 86% of all cases requiring microscopic examination were coded as Level IV (88305). Level III and Level V each accounted for roughly 6 to 7%, while Level II made up less than 1% and Level VI less than half a percent.¹ This lopsided distribution reflects how modern medicine generates tissue samples. The most common reasons for a biopsy, whether it is a suspicious skin lesion, a gastrointestinal polyp found during a colonoscopy, or a breast lump detected on imaging, all funnel into Level IV.

The dominance of Level IV also reflects how the CPT manual is structured. The level is intentionally broad, catching everything from a simple punch biopsy of the skin to a bone marrow biopsy with clinical correlation. Levels V and VI, by contrast, are reserved for major surgical resections that typically arise only when cancer has already been diagnosed and the patient needs a larger operation.

Gross-Only Examination at the Lower Levels

Level I is unique because it is the only tier where no microscope slides are made at all. The pathologist or assistant visually inspects the specimen, describes it, and that is the end of it. Level II specimens do get microscopic slides, but the diagnostic questions are narrow enough that the examination is relatively quick.

In recent years, some academic pathology departments have been expanding the list of specimen types they handle with a “gross-only” approach, meaning the tissue is examined by eye and described but not processed for microscopy. The goal is to reduce waste and pathologist time without compromising patient safety. One multi-institution review identified 63 candidate specimen types that could potentially be handled this way, and about half of those were already being processed as gross-only at at least one academic center.² This matters because every slide that gets made costs reagents, technician time, and pathologist attention. Skipping slides on specimens that almost never yield a meaningful microscopic finding lets the lab redirect resources toward harder cases.

That said, the decision to skip microscopy is not taken lightly. A specimen that is overwhelmingly benign 99% of the time can still harbor a rare incidental finding. Policies for gross-only handling tend to be institution-specific, with safety committees reviewing outcome data before adding new specimen types to the list.

How the Levels Connect to Billing and Workload

Each level carries a work Relative Value Unit (RVU) assignment that reflects the expected amount of physician effort. The gap between levels is not linear. Based on the rates used by the Centers for Medicare and Medicaid Services, Level I carried 0.08 RVUs, Level II carried 0.13, Level III was 0.22, Level IV jumped to 0.75, Level V rose to 1.59, and Level VI reached 2.80.³ The big leap from Level III to Level IV reflects the fact that Level IV is where genuine diagnostic interpretation begins for most specimens. Levels V and VI then roughly double with each step, reflecting the additional grossing, sectioning, and diagnostic complexity.

RVUs are the currency that determines how pathologists and labs are compensated under Medicare and many private insurance contracts. Because Level IV constitutes such a large share of total cases, even small shifts in the case mix between levels can meaningfully change a department’s revenue and workload metrics. During the early phase of the COVID-19 pandemic, for instance, elective procedures dropped sharply. One analysis found that the proportion of higher-level codes (Levels V and VI) increased relative to lower-level codes during 2020 compared with 2019, though the shift was not statistically significant.⁴ The likely explanation is straightforward: screening biopsies and minor procedures were postponed, while cancer surgeries continued, skewing the mix toward more complex specimens.

Coding Controversies and Gray Areas

Assigning a specimen to the correct level sounds mechanical, but it involves several judgment calls that pathologists and coders disagree about regularly. One recurring issue is the distinction between a “specimen” and a “container.” If a surgeon sends two skin biopsies from different sites in the same jar, is that one specimen or two? The answer affects how many units get billed. The CPT manual’s guidance on this point has been debated for years, and different institutions interpret it differently.⁵

Another gray area is “bundling” versus “unbundling.” When a large specimen contains multiple distinct tissue types, should each tissue type be coded separately, or should the whole specimen be coded once at the highest applicable level? For example, a colon resection for cancer includes the tumor itself, surrounding normal colon, lymph nodes, and sometimes additional margins. The general principle is that a single specimen gets one code, but when the pathologist separately examines and reports on distinct components (especially lymph nodes), separate coding may be warranted. Auditors watch for both over-unbundling (billing for more units than the work justifies) and over-bundling (under-billing in a way that misrepresents the work done).

A related complication is that the CPT level is supposed to be based on the specimen type and the clinical scenario, not on the final diagnosis. In practice, though, the diagnosis can influence how much work the pathologist actually performs. A skin biopsy that looks benign under the microscope takes a few minutes of a pathologist’s time. The same type of biopsy showing a melanoma may require additional sections, deeper cuts, and extensive documentation. Both are coded at Level IV, but the actual effort differs substantially. This tension between standardized coding and variable real-world effort is a persistent source of frustration in the field.

Add-On Procedures Beyond the Base Level

The six levels cover the basic work of examining a surgical specimen, but many cases require additional procedures that are billed separately. These are not “levels” in the formal sense, but they often surprise patients and administrators who expect a single pathology charge per specimen.

Special stains are one common add-on. When the standard staining method does not provide enough information to make a diagnosis, the pathologist orders histochemical stains that highlight specific tissue features like mucin, fungi, or collagen. Each special stain is billed under its own CPT code, separate from the base surgical pathology level.

Immunohistochemistry (IHC) is an even more common addition, particularly in cancer diagnosis. IHC uses antibodies to detect specific proteins in tissue, helping pathologists determine whether a tumor is benign or malignant, what type of cancer it is, or whether certain treatment targets are present. In one study of melanoma diagnoses, IHC was used in about 64% of cases, with higher utilization for melanoma in situ than for invasive melanoma.⁶ Each antibody panel adds to the bill, and complex cases can involve a dozen or more individual stains on top of the base surgical pathology charge.

Frozen sections are another add-on. When a surgeon needs a preliminary diagnosis during an operation, tissue is rapidly frozen, sliced, stained, and read by a pathologist within minutes. This intraoperative consultation is billed separately and does not change the base surgical pathology level of the specimen, which will still be processed through the full permanent-section protocol afterward.

Molecular testing, including gene sequencing and fluorescence in situ hybridization (FISH), represents yet another layer of charges. These tests have become standard of care in many cancer types, guiding targeted therapy decisions. They operate entirely outside the six-level surgical pathology framework, under their own set of CPT codes.

Machine Learning and Automated Code Assignment

Given that the vast majority of cases fall into Level IV, you might wonder whether a computer could just assign CPT codes automatically. Researchers have been exploring exactly that. Machine-learning models trained on the text of pathology reports can predict the correct primary CPT code with reasonable accuracy. In one study comparing different algorithms, the best-performing model achieved agreement with human coders in the range of 83 to 86% across all five levels that involve microscopic examination.¹

That performance is impressive for a fully automated system, but the errors tend to cluster around the boundary between levels, exactly where the coding controversies discussed earlier live. A machine that reads “colon, biopsy” in the report will almost always get Level IV right. But a machine trying to decide whether a complex specimen should be Level IV or Level V faces the same ambiguity a human coder does, plus it lacks the context of having seen the actual tissue.

For now, automated coding serves more as a decision-support tool than a replacement for human coders. It can flag cases where the predicted code does not match what was manually assigned, which is useful for catching both coding errors and potential compliance issues. Full automation remains limited by the fact that coding rules involve institutional policy decisions and clinical nuance that text alone does not always capture.

Why Patients Rarely See the Level Number

If you have ever received a pathology bill, you probably noticed it did not say “Level IV surgical pathology” anywhere obvious. The CPT code shows up on the explanation of benefits or the itemized bill, but it is rarely explained to the patient. Most people interact with surgical pathology through the diagnostic report, which tells them whether the biopsy was benign, malignant, or something in between. The level assignment is essentially an internal accounting mechanism that determines how much the lab charges and how much work credit the pathologist receives.

This invisibility can create confusion when patients see multiple pathology charges for what they thought was a single biopsy. If the surgeon biopsied three sites, the lab may bill three separate Level IV charges. If the pathologist ordered special stains or IHC, those appear as additional line items. And if a frozen section was performed during surgery, that is yet another charge. Understanding that each of these represents a distinct piece of diagnostic work can help make sense of what otherwise looks like an inflated bill.

The six-level system has been in place for decades and, despite its quirks, has proven durable. Proposals to revise or simplify it surface periodically, but the entrenched infrastructure of billing, reimbursement, and compliance built around these codes makes major changes slow to implement. For the foreseeable future, surgical pathology in the United States runs on six levels, with Level IV carrying the overwhelming majority of the load.